Zobrazeno 1 - 10
of 305
pro vyhledávání: '"hematologic cancer"'
Incidence of hematologic cancer types in Japan by ICD-O-3 code: analysis of National Cancer Registry
Autor:
Ayako Muramatsu, Tetsuji Kawakami
Publikováno v:
Future Science OA, Vol 10, Iss 1 (2024)
Aim: We classified subtypes of hematologic cancer in Japan’s National Cancer Registry (NCR) in 2016 by ICD-O-3 code and compared numbers with the Japanese Society of Hematology’s Blood Diseases Registry (BDR).Materials & methods: We reviewed data
Externí odkaz:
https://doaj.org/article/6351eaf2d6394b918ee5988022562969
Autor:
Hochrath, Sophie a, ⁎, Dhollander, Naomi a, Deliens, Luc a, Schots, Rik c, e, Daenen, Frederick a, Kerre, Tessa d, f, Beernaert, Kim b, 1, Pardon, Koen a, 1
Publikováno v:
In Journal of Pain and Symptom Management January 2025 69(1):114-133
Publikováno v:
Open Life Sciences, Vol 19, Iss 1, Pp 2962-72 (2024)
Bortezomib (BTZ), a proteasome inhibitor, is a promising therapeutic option for multiple myeloma (MM) patients. However, drug resistance often occurs, leading to disease relapse and poor prognosis. In this study, we aimed to identify novel genes asso
Externí odkaz:
https://doaj.org/article/7182aacdb063460cbfac8dd3de4438ae
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground Galectin (Gal) is considered a promising immune checkpoint molecule. More and more studies have shown that high expression levels of galectins in hematologic cancer are positively correlated with poor clinical prognosis. However, t
Externí odkaz:
https://doaj.org/article/b70a1e2078484709b3b0b7a0680153aa
Publikováno v:
Reproductive Health, Vol 20, Iss 1, Pp 1-9 (2023)
Plain language summary Premature ovarian insufficiency is the onset of premature menopause in individuals less than 40-years-old. Previous research has shown that there is a higher risk of premature ovarian insufficiency in adolescent and young adult
Externí odkaz:
https://doaj.org/article/bcc197045dce448e84b01cd2c07d7359
Autor:
Patricia Guevara-Ramírez, Santiago Cadena-Ullauri, Elius Paz-Cruz, Rafael Tamayo-Trujillo, Viviana A. Ruiz-Pozo, Ana Karina Zambrano
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Hematologic neoplasms represent 6.5% of all cancers worldwide. They are characterized by the uncontrolled growth of hematopoietic and lymphoid cells and a decreased immune system efficacy. Pathological conditions in hematologic cancer could disrupt t
Externí odkaz:
https://doaj.org/article/5dd2acfb9184416b93252e5a4f7ae60d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zahraa Haleem Al-qaim, Hasanain Kamil Hasan Owadh, Sarah A. Ali, Alaa S. Hussein, Thamer Ramadhan Ameen, Ayshan Kolemen, Ghassan A. Washi, Abduladheem Turki Jalil
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The rapid spread of the SARS-Cov-2 virus, the increase in the number of patients with severe COVID-19, and the high mortality rate created the basis for the production of safe and effective vaccines. Studies have confirmed the increased risk of sever
Externí odkaz:
https://doaj.org/article/409bb2108f574dd8ae73a6c09163579b
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 185-190 (2021)
Introduction: Multiple myeloma is a progressive and incurable hematological disease characterized by disordered and clonal multiplication of plasmacytes in the bone marrow. The main clinical manifestations are caused by the presence of neoplastic cel
Externí odkaz:
https://doaj.org/article/0e85d305251f47fc820d3ded45d5d34e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.